Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
A synthetic research peptide studied around the biology of cellular senescence, cellular aging, and longevity-related signaling, with particular interest in the molecular mechanisms that allow senescent cells to persist.
FOXO4-DRI is a cell-penetrating peptide designed to interfere with the interaction between the transcription factor FOXO4 and the tumor-suppressor protein p53. Preclinical research has investigated whether disrupting this interaction can influence survival pathways in certain senescent cells. This has made FOXO4-DRI an experimental tool in the study of senescence and senolytic biology, but evidence remains predominantly preclinical, and FOXO4-DRI is not an FDA-approved medication.
Research Focus: Cellular Senescence • FOXO4-p53 Signaling • Senolytic Biology • Cellular Aging • Apoptosis Pathways • Longevity Research • Cellular Stress Responses
An experimental research peptide for those interested in the science of cellular aging, senescent-cell biology, longevity pathways, and the molecular signaling mechanisms involved in cellular survival and turnover.
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.
A synthetic research peptide studied around the biology of cellular senescence, cellular aging, and longevity-related signaling, with particular interest in the molecular mechanisms that allow senescent cells to persist.
FOXO4-DRI is a cell-penetrating peptide designed to interfere with the interaction between the transcription factor FOXO4 and the tumor-suppressor protein p53. Preclinical research has investigated whether disrupting this interaction can influence survival pathways in certain senescent cells. This has made FOXO4-DRI an experimental tool in the study of senescence and senolytic biology, but evidence remains predominantly preclinical, and FOXO4-DRI is not an FDA-approved medication.
Research Focus: Cellular Senescence • FOXO4-p53 Signaling • Senolytic Biology • Cellular Aging • Apoptosis Pathways • Longevity Research • Cellular Stress Responses
An experimental research peptide for those interested in the science of cellular aging, senescent-cell biology, longevity pathways, and the molecular signaling mechanisms involved in cellular survival and turnover.
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.